Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients ↑	Dosage	Form	Price
L02BX03	ABIRATERONE ACETATE NEAPOLIS	G	Abiraterone acetate - 250mg	250mg	Tablet	75,418,662 L.L
L02BX03	ABIRATERONE ACETATE SPC	G	Abiraterone acetate - 250mg	250mg	Tablet, film coated	92,278,660 L.L
L02BX03	ABLAX 250	G	Abiraterone acetate - 250mg	250mg	Tablet	45,056,853 L.L
L02BX03	ABREMIA	G	Abiraterone acetate - 250mg	250mg	Tablet	77,478,802 L.L
L02BX03	ABREMIA	G	Abiraterone acetate - 250mg	250mg	Tablet	L.L
L02BX03	ABLAX 250	G	Abiraterone acetate - 250mg	250mg	Tablet	L.L
L02BX03	ABLAX 500	G	Abiraterone acetate - 500mg	500mg	Tablet	45,056,853 L.L
L02BX03	APO-ABIRATERONE	G	Abiraterone acetate - 500mg	500mg	Tablet, film coated	46,110,590 L.L
L02BX03	ABLAX 500	G	Abiraterone acetate - 500mg	500mg	Tablet	L.L
N07BB03	ACAMPROSATE BIOGARAN	G	Acamprosate - 333mg	333mg	Tablet, gastroresistant	3,641,813 L.L
C07AB04	ACEBUTOLOL BIOGARAN	G	Acebutolol HCl - 200mg	200mg	Tablet, coated	464,970 L.L
C07AB04	ACEBUTOLOL BIOGARAN	G	Acebutolol HCl - 400mg	400mg	Tablet, coated	615,480 L.L
M02AA	AIRTAL DIFUCREM 1.5%	B	Aceclofenac - 1.5g/100g	1.5%	Cream	536,193 L.L
M01AB16	AIRTAL 100MG 20	B	Aceclofenac - 100mg	100mg	Tablet, film coated	471,689 L.L
M01AB16	ACECLOFAR	G	Aceclofenac - 100mg	100mg	Tablet	131,697 L.L
M01AB16	ARACENAC	G	Aceclofenac - 100mg	100mg	Tablet, film coated	330,585 L.L
S01EC01	ACETAZOLAMIDE	G	Acetazolamide - 250mg	250mg	Tablet	1,001,163 L.L
B01AC06	ASPIRIN PROTECT	B	Acetylsalicylic acid - 100mg	100mg	Tablet, enteric coated	146,479 L.L
B01AC06	ASPICOT	G	Acetylsalicylic acid - 100mg	100mg	Tablet, enteric coated	403,153 L.L
B01AC06	ASPICOT	G	Acetylsalicylic acid - 100mg	100mg	Tablet, enteric coated	134,384 L.L
B01AC06	ASPIPHAR	G	Acetylsalicylic acid - 100mg	100mg	Tablet, enteric coated	134,384 L.L
N02BA01	ASPIRINE	B	Acetylsalicylic acid - 300mg	0.3g	Tablet	80,631 L.L
N02BA51	ASPIRINE C EFFERVESCENT	B	Acetylsalicylic acid - 400mg, Vitamin C - 240mg		Tablet, effervescent	162,605 L.L
N02BA51	ASPRIVIT	G	Acetylsalicylic acid - 500mg, Caffeine - 50mg, Vitamin B1 - 2mg		Tablet	186,794 L.L
B01AC06	A.S HEART	G	Acetylsalicylic acid - 81mg	81mg	Tablet, enteric coated	148,463 L.L
B01AC06	ASPI-COR	G	Acetylsalicylic acid - 81mg	81mg	Tablet, enteric coated	690,735 L.L
B01AC06	ASPICOT	G	Acetylsalicylic acid - 81mg	81mg	Tablet, enteric coated	353,239 L.L
B01AC06	ASPROTHIN	G	Acetylsalicylic acid - 81mg	81mg	Tablet, enteric coated	148,463 L.L
J05AB01	ACTI-VIR	G	Aciclovir - 200mg	200mg	Tablet, scored	1,039,238 L.L
J05AB01	ASIMPLEX	G	Aciclovir - 250mg	250mg	Injectable lyophilised powder for solution	278,175 L.L

...